Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shot up 1% during mid-day trading on Thursday . The stock traded as high as $50.50 and last traded at $50.50. 2,107 shares traded hands during mid-day trading, an increase of 85% from the average session volume of 1,136 shares. The stock had previously closed at $50.00.
Hikma Pharmaceuticals Stock Performance
The firm’s 50-day moving average price is $49.05 and its 200 day moving average price is $50.01.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Further Reading
- Five stocks we like better than Hikma Pharmaceuticals
- How to Invest in the Best Canadian Stocks
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Top Stocks Investing in 5G Technology
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Investing in Commodities: What Are They? How to Invest in Them
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
